logo
logo

Medtech Baymatob Completes Capital Raise To Advance Life-Saving Labor Monitoring Device

Mar 29, 2022•over 3 years ago
Sydney

Description

Medical device company Baymatob has completed a placement of A$4.215 million, with proceeds used to continue in-human clinical trials for its AI-guided labor monitoring device, Oli.

Company Information

Company

Baymatob

Location

Sydney, New South Wales, Australia

About

Baymatob was founded after a traumatic birth experience and aims to transform outcomes for mothers and their babies. The company's flagship product Oli is a platform technology that will provide world-first, definitive clinical diagnoses, that have never-before been seen within pregnancy and labor monitoring. The first of these being a post-partum hemorrhage advance diagnostic capability. Baymatob, with its Oli technology, holds a rare opportunity to truly and completely transform clinical practice, disrupting decades-old technologies, with completely novel and impactful predictive diagnoses.